Compare · CELL vs SQZ
CELL vs SQZ
Side-by-side comparison of PhenomeX Inc. (CELL) and SQZ Biotechnologies Company (SQZ): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELL and SQZ operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- Company
- PhenomeX Inc.
- SQZ Biotechnologies Company
- Price
- -
- -
- Market cap
- -
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
SQZ Biotechnologies Company
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
Latest CELL
- PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform
- PhenomeX Announces The Release Of SpotLight Human Lambda Reagent For The Beacon Platform To Accelerate Cell Line Development Workflows
- PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows
- PhenomeX to Participate in Upcoming Cell Biology Conferences
- PhenomeX Unveils Meteor Chips For Quantitative Bulk Analysis On The IsoSpark Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomic
- PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics
- PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
- Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares
- Lifshitz Law PLLC Announces Investigations of TMBR, PR, ESTE, and CELL
- Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2023
Latest SQZ
- SEC Form SC 13G/A filed by SQZ Biotechnologies Company (Amendment)
- SEC Form SC 13G/A filed by SQZ Biotechnologies Company (Amendment)
- SEC Form DEFM14A filed by SQZ Biotechnologies Company
- SEC Form PREM14A filed by SQZ Biotechnologies Company
- SEC Form 15-12G filed by SQZ Biotechnologies Company
- SQZ Biotechnologies Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form EFFECT filed by SQZ Biotechnologies Company
- SEC Form POS AM filed by SQZ Biotechnologies Company
- SEC Form S-8 POS filed by SQZ Biotechnologies Company
- SEC Form 10-Q filed by SQZ Biotechnologies Company